These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32551871)

  • 1. Volume computed tomography perfusion as a predictive marker for treatment response to concurrent chemoradiotherapy in cervical cancer: a prospective study.
    Dong Rui T; Dong Y; Song Qing L; Tong R; Wang Fei F; Yu T; Luo Y
    Acta Radiol; 2021 Feb; 62(2):281-288. PubMed ID: 32551871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Features of the Whole Uterus Volume CT Perfusion and Influence Factors of Blood Supply: A Primary Study in Patients with Cervical Squamous Carcinoma.
    Yue D; Tong DR; Fei Fei W; Miao ZX; Ting PH; Tao Y; Ya Hong L
    Acad Radiol; 2019 Aug; 26(8):e216-e223. PubMed ID: 30201435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of perfusion CT in predicting the short-term response to synchronous radiochemotherapy for cervical squamous cancer.
    Li XS; Fan HX; Zhu HX; Song YL; Zhou CW
    Eur Radiol; 2012 Mar; 22(3):617-24. PubMed ID: 21960157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular permeability determined using multi-slice spiral CT perfusion can predict response to chemoradiotherapy in patients with advanced cervical squamous cell carcinoma
.
    Liu J; Fan H; Qiu GP
    Int J Clin Pharmacol Ther; 2017 Jul; 55(7):619-626. PubMed ID: 28291509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Application of Iodine Quantitative Information Obtained by Dual-Source Dual-Energy Computed Tomography on Chemoradiotherapy Effect Monitoring for Cervical Cancer: A Preliminary Study.
    Jiang C; Yang P; Lei J; Li J; Yan K; Li F; Yan R; Xia L
    J Comput Assist Tomogr; 2017; 41(5):737-745. PubMed ID: 28448413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting and Early Monitoring Treatment Efficiency of Cervical Cancer Under Concurrent Chemoradiotherapy by Intravoxel Incoherent Motion Magnetic Resonance Imaging.
    Zhu L; Zhu L; Wang H; Yan J; Liu B; Chen W; He J; Zhou Z; Yang X
    J Comput Assist Tomogr; 2017; 41(3):422-429. PubMed ID: 27824669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors.
    Yang W; Qiang JW; Tian HP; Chen B; Wang AJ; Zhao JG
    Eur Radiol; 2018 Jan; 28(1):437-445. PubMed ID: 28779395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [
    Shen WC; Chen SW; Wu KC; Hsieh TC; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yen KY; Kao CH
    Eur Radiol; 2019 Dec; 29(12):6741-6749. PubMed ID: 31134366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Multislice Spiral Computed Tomography Perfusion Imaging for the Efficacy of Preoperative Concurrent Chemoradiotherapy in Middle-aged and Elderly Patients with Locally Advanced Gastric Cancer.
    Liang JX; Bi XJ; Li XM; Gao ZL; Suo F; Cui EG; Li HF; Lv HL
    Med Sci Monit; 2018 Jan; 24():235-245. PubMed ID: 29326419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of disease progression following concurrent chemoradiotherapy for uterine cervical cancer: value of post-treatment diffusion-weighted imaging.
    Park JJ; Kim CK; Park BK
    Eur Radiol; 2016 Sep; 26(9):3272-9. PubMed ID: 26685853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early treatment response of patients undergoing concurrent chemoradiotherapy for cervical cancer: An evaluation of integrated multi-parameter PET-IVIM MR.
    Xu C; Sun H; Du S; Xin J
    Eur J Radiol; 2019 Aug; 117():1-8. PubMed ID: 31307633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histogram analysis of apparent diffusion coefficient for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
    Meng J; Zhu L; Zhu L; Ge Y; He J; Zhou Z; Yang X
    Acta Radiol; 2017 Nov; 58(11):1400-1408. PubMed ID: 28273745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy.
    Su TP; Lin G; Huang YT; Liu FY; Wang CC; Chao A; Chou HH; Yen TC; Lai CH
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):727-734. PubMed ID: 29159572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain elastography as an early predictor of long-term prognosis in patients with locally advanced cervical cancers treated with concurrent chemoradiotherapy.
    Xu Y; Zhu L; Zhu L; Wang H; Ru T; Liu B; He J; Tian S; Zhou Z; Yang X
    Eur Radiol; 2020 Jan; 30(1):471-481. PubMed ID: 31359126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early response of patients undergoing concurrent chemoradiotherapy for cervical cancer: a comparison of PET/CT and MRI.
    Lee JE; Huh SJ; Nam H; Ju SG
    Ann Nucl Med; 2013 Jan; 27(1):37-45. PubMed ID: 23054833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of Short-Term Imaging and Squamous Cell Carcinoma Antigen to Early Predict Response to Concurrent Chemoradiotherapy in Patients With Cervical Cancer.
    Yoo JG; Kim SI; Yeo SG; Park DC
    Cancer Control; 2022; 29():10732748221074530. PubMed ID: 35196888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?
    Bae JM; Kim CK; Park JJ; Park BK
    Abdom Radiol (NY); 2016 Aug; 41(8):1604-10. PubMed ID: 27056747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer.
    Makino H; Kato H; Furui T; Morishige K; Kanematsu M
    J Obstet Gynaecol Res; 2014 Apr; 40(4):1098-104. PubMed ID: 24320754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of diffusion-weighted magnetic resonance imaging and
    Park JJ; Kim CK; Park BK
    Radiother Oncol; 2016 Sep; 120(3):507-511. PubMed ID: 26900089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy.
    Gu KW; Kim CK; Choi CH; Yoon YC; Park W
    Eur Radiol; 2019 Nov; 29(11):6236-6244. PubMed ID: 30980126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.